Our immune system is vital in protecting us from illnesses. Yet in many cases, the immune system can malfunction, underreacting or overreacting to a real or perceived threat. The field of immunology has long been at the heart of what we do at Sobi, allowing us to gain extensive experience over many years.
Sobi’s Immunology portfolio enables the treatment of serious, disabling or even life-threatening diseases. With our understanding of the mechanisms involved, we are studying how our existing products can potentially help in new indications, and we continue to search for new late-stage treatment candidates that show promise in other areas of unmet medical need.
Building on our history of making innovative therapies available to the people who need them, we continue to work with healthcare professionals, patient organizations and other stakeholders to get our treatments to as many patients as possible.
Sobi’s focus within immunology
Familial Mediterranean fever (FMF)
FMF is an autoinflammatory genetic disorder that mainly affects people of Mediterranean or Middle Eastern origin, characterised by recurrent episodes of fever and serositis (an inflammation in chest, abdomen, joints), leading to painful attacks early during childhood.
Cryopyrin- associated periodic syndromes (CAPS)
CAPS are a group of rare, autoinflammatory disorders that includes familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS), and neonatal-onset multisystem inflammatory disease (NOMID).
Haemophagocytic lympho-histiocytosis (HLH)
A rare, life-threatening condition caused by an overactive, abnormal response of the immune system. In heamophagocytic lymphohistiocytosis, the immune system responds to a stimulus or ‘trigger’, often an infection, but the response is ineffective and abnormal.
Respiratory syncytial virus (RSV)
A common virus and the most common cause of lower respiratory tract infections in young children. The RSV season usually occurs from early autumn until late spring and peaks during the winter.
Still´s Disease
A rare systemic autoinflammatory disease characterised by fevers, rash, and joint pain. Still’s disease includes Systemic juvenile idiopathic arthritis (SJIA) and Adult-Onset Still's disease (AOSD) which share symptoms but vary in frequency and presentation. A potentially fatal complication is macrophage activation syndrome (MAS).
Therapeutic areas
Learn more about all our therapeutic areas spanning - Immunology, Haematology and Specialty Care.
Development pipeline
We see innovation as essential to our vision of being a global leader in rare diseases. We invest in research and development to continue to provide innovative treatments.